Genprex

GNPXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.156 M

$4.27 -3.83%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$16.2M

Loss-making

Shares outstanding

9,044,856

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#495Decoy TherapeuticsDCOY$2.32M
#496AzitraAZTR$2.19M
#497GenprexGNPX$2.16M
#498Matinas BioPharmaMTNB$1.81M
#499China SXT PharmaceuticalsSXTC$1.74M

Where these numbers come from

Share counts and financials for Genprex are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.